Shah Wealth Advisors LLC Acquires 85,476 Shares of SPDR S&P Biotech ETF $XBI

Shah Wealth Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 3rd quarter, Holdings Channel.com reports. The fund acquired 85,476 shares of the exchange traded fund’s stock, valued at approximately $13,478,000. SPDR S&P Biotech ETF comprises approximately 2.7% of Shah Wealth Advisors LLC’s portfolio, making the stock its 14th biggest position.

A number of other hedge funds and other institutional investors have also made changes to their positions in XBI. Bank of America Corp DE lifted its position in SPDR S&P Biotech ETF by 13.3% in the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after acquiring an additional 1,700,851 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in shares of SPDR S&P Biotech ETF by 145.7% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock valued at $49,726,000 after purchasing an additional 186,314 shares during the period. Annex Advisory Services LLC raised its stake in shares of SPDR S&P Biotech ETF by 4.6% in the 3rd quarter. Annex Advisory Services LLC now owns 266,485 shares of the exchange traded fund’s stock valued at $42,019,000 after purchasing an additional 11,723 shares during the period. Moss Adams Wealth Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at about $30,841,000. Finally, Sivik Global Healthcare LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 20.0% in the third quarter. Sivik Global Healthcare LLC now owns 180,000 shares of the exchange traded fund’s stock valued at $28,382,000 after purchasing an additional 30,000 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $150.55 on Monday. The stock has a market capitalization of $10.20 billion, a P/E ratio of 20.64 and a beta of 0.87. The business has a 50-day moving average of $154.26 and a 200-day moving average of $142.92. SPDR S&P Biotech ETF has a fifty-two week low of $111.11 and a fifty-two week high of $169.89.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Recommended Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.